Dear Arty,
Induced pluripotent stem cell therapies pose significant unique challenges with respect to safety, potency, genetic stability, immunogenicity, tumorgenicity, cell reproducibility and scalability.
You have shown yourself to be a hater of first responders and made comments about my family.
I try to keep it civil and report what I see and read and I genuinely feel that CYP is a decade away at a minimum if it survives.
Nobody here will agree as they are invested and can't sell out as it isn't a stock that trades being a penny hopefull.
There is a decade to go before IPSC's are on the commercial books, if ever.
Ann: Publication comparing Cymerus MSCs to other MSCs, page-63
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
16.5¢ |
Change
-0.005(2.94%) |
Mkt cap ! $37.28M | |||
| Open | High | Low | Value | Volume |
| 16.5¢ | 17.0¢ | 16.5¢ | $39.66K | 238.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 277684 | 16.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 17.5¢ | 14285 | 1 |
View Market Depth
| Last trade - 16.10pm 16/06/2025 (20 minute delay) ? |
| CYP (ASX) Chart |